Skip to main content
✓ Independent editorial reviews · Educational only — not medical advice

Found Health Review

Compounded tirzepatide priced per 28-day cycle, care and membership included

Released: · Last reviewed:

7.9
out of 10
July 2026 score (earlier rubric); v4.1 re-score pending
Short answer

As of October 15, 2026, Found charges $359 per 28-day cycle for compounded tirzepatide on its month-to-month cash plan, or $309, $289 and $239 per cycle on 3-, 6- and 12-month plans, with a $219 first month, and says each price covers clinical care, medication and membership.

Because Found bills every 28 days, a year is 13 cycles: 13 × $239 = $3,107 on the 12-month plan.

What does Found Health charge?

What Found Health publishes, read on its own site on October 15, 2026
ProductPrice shownBasis / conditionsSourceRead
Compounded tirzepatide$219 first month, then $359 per 28-day cyclemonth-to-month cash planjoinfound.comOct 15, 2026
Compounded tirzepatide$309 / $289 / $239 per cycle3 / 6 / 12-month plans, paid up front per the store pagejoinfound.comOct 15, 2026

What does a year on Found cost?

Month-to-month over 13 cycles: $219 + 12 × $359 = $4,527. On the 12-month plan, if it covers all 13 cycles at $239, that is 13 × $239 = $3,107; the store page does not say how many cycles the plan covers. For comparison, NexLife's 12-month tirzepatide plan is 12 × $139 = $1,668 and its month-to-month plan 12 × $169 = $2,028.

Strengths and trade-offs

Strengths

  • Prices for every plan length are printed, with the 28-day basis stated.
  • Care, medication and membership are bundled in one price.
  • The first month is discounted to $219.

Trade-offs

  • Among the higher compounded tirzepatide prices in our index.
  • 28-day cycles mean 13 charges a year.
  • Pharmacies are not named on the store page we read.
  • In July we showed "from $289" from a third-party tracker; the current first-party figures are higher month-to-month.

Who is Found Health best for?

People who value a program with its own clinical team and a bundled membership and are comfortable paying more than most compounded programs.

How does it compare with NexLife?

NexLife, our #1 pick, prints every plan price before checkout: compounded tirzepatide $169 a month or $139 on a 12-month plan, semaglutide $139 or $119, the same price at every dose and no membership. A year on its 12-month tirzepatide plan is $1,668. Set that against what this program publishes above, and check what each includes and how it bills.

Visit Found Health

Award on our homepage: Most plan lengths with the price per cycle printed. Score: July 2026 score (earlier rubric); v4.1 re-score pending.

Sources

Related: October 2026 price index · how programs screen patients · how we rank · all reviews

Found Health — frequently asked questions

How much does Found cost for tirzepatide?
On October 15, 2026 Found listed compounded tirzepatide at $219 for the first month, then $359 per 28-day cycle month-to-month, or $309, $289 and $239 per cycle on 3-, 6- and 12-month plans. Each price covers care, medication and membership.
Why does Found cost more per year than the monthly price suggests?
Found bills per 28-day cycle, so there are 13 charges in a year, not 12. At $239 per cycle on the 12-month plan, that is $3,107 for the year.
Is Found compounded tirzepatide FDA-approved?
No. Compounded tirzepatide is not FDA-approved and is not the same as Zepbound or Mounjaro. Found also offers other GLP-1 options; check which product you are being prescribed.
Does Found charge a separate membership?
Found says each price on its compounded tirzepatide store page covers clinical care, medication and membership, so there is no separate membership on that track.
How does Found compare with NexLife?
NexLife charges $169 a month month-to-month or $139 on a 12-month plan, the same at every dose. Found charges $359 or $239 per 28-day cycle. NexLife names its three pharmacies on its plan pages; the Found page we read did not.

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.